Climate change is significantly impacting respiratory health, with pollution and wildfires exacerbating conditions like asthma and COPD. Health systems contribute to global warming, generating about 5% of greenhouse gas emissions. Inhalers, commonly used for respiratory diseases, emit millions of tonnes of CO₂-equivalent annually. Efforts are underway to develop greener inhalers and reduce emissions in the pharmaceutical industry, with companies like AstraZeneca and Pfizer committing to significant reductions. Teljes cikk (Euronews.com)